Phase 3 accelerated approval trial of IFx-2.0 as adjunctive therapy with Keytruda® (pembrolizumab) as a first-line therapy ...

According to thierry Ehrmann, Founder of Artprice and CEO of Artmarket.com: "With the launch of Artprice News®, we are taking ...

November 14, 2025) – Damon Inc. (OTCID: DMNIF) (“Damon” or the “Company”), a designer and developer of electric motorcycles and other personal mobility products that seek to empower the personal ...